Enantioselectivity in the metabolism of cyclophosphamide in patients with multiple or systemic sclerosis (2017)
- Authors:
- USP affiliated authors: SIMOES, BELINDA PINTO - FMRP ; COELHO, EDUARDO BARBOSA - FMRP ; LANCHOTE, VERA LUCIA - FCFRP
- Unidades: FMRP; FCFRP
- DOI: 10.1002/jcph.863
- Subjects: CITOCINAS; FÁRMACOS IMUNOSSUPRESSORES; ESCLEROSE MÚLTIPLA
- Keywords: Pharmacokinetics; Metabolism; Cyclophosphamide enantiomers; Multiple sclerosis; Systemic sclerosis
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: The Journal of Clinical Pharmacology
- ISSN: 0091-2700
- Volume/Número/Paginação/Ano: v. 57, n. 6, p. 784-795, 2017
- Status:
- Artigo possui versão em acesso aberto em repositório (Green Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
CASTRO, Francine Attié de et al. Enantioselectivity in the metabolism of cyclophosphamide in patients with multiple or systemic sclerosis. The Journal of Clinical Pharmacology, v. 57, n. 6, p. 784-795, 2017Tradução . . Disponível em: https://doi.org/10.1002/jcph.863. Acesso em: 01 abr. 2026. -
APA
Castro, F. A. de, Simões, B. P., Coelho, E. B., & Lanchote, V. L. (2017). Enantioselectivity in the metabolism of cyclophosphamide in patients with multiple or systemic sclerosis. The Journal of Clinical Pharmacology, 57( 6), 784-795. doi:10.1002/jcph.863 -
NLM
Castro FA de, Simões BP, Coelho EB, Lanchote VL. Enantioselectivity in the metabolism of cyclophosphamide in patients with multiple or systemic sclerosis [Internet]. The Journal of Clinical Pharmacology. 2017 ; 57( 6): 784-795.[citado 2026 abr. 01 ] Available from: https://doi.org/10.1002/jcph.863 -
Vancouver
Castro FA de, Simões BP, Coelho EB, Lanchote VL. Enantioselectivity in the metabolism of cyclophosphamide in patients with multiple or systemic sclerosis [Internet]. The Journal of Clinical Pharmacology. 2017 ; 57( 6): 784-795.[citado 2026 abr. 01 ] Available from: https://doi.org/10.1002/jcph.863 - Use of an oral busulfan test dose in patients undergoing hematopoietic stem cell transplantation treated with or without fludarabine
- Influence of quinidine, fluvoxamine, and ketoconazole on the enantioseletive pharmacokinetics of citalopram in rats
- Enantioselectivity in the pharmacokinetic interaction between fluvastatin and lercanidipine in healthy volunteers
- Influence of type-2 diabetes mellitus on the stereoselective kinetic disposition of fluvastatin
- Stereoselective analysis of metoprolol and its metabolites inrat plasma with application to oxidative metabolism
- Effects of type 2 diabetes mellitus in patients on treatment with glibenclamide and metformin on carvedilol enantiomers metabolism
- Effect of hypertension on the stereoselective pharmacokinetics of fluvastatin in rats
- Lercanidipine-fluvastatin interaction: pharmacokinetics stereoselectivity in experimental study
- Enantioselectivity in fluvastatin-lercanidipine pharmacokinetics interaction in healthy volunteers
- Chiral evaluation of fluvastatin in human plasma by high-performance liquid chromatography electrospray mass spectometry
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
